Lung Cancer Europe updates its identity

Lung Cancer Europe new icon line drawing

From 1 July 2026, we are using our full name, Lung Cancer Europe, across everything we do.

For many years, LuCE worked well as a short name. It was familiar to our members, partners and the people closest to the organisation. It carried history, trust and recognition.

But Lung Cancer Europe has grown.

Our work now reaches across Europe and beyond. We work with member organisations, advocates, researchers, clinicians, policymakers, partners and people affected by lung cancer. We need our name to be clear to someone who has known us for years, and just as clear to someone finding us for the first time.

That is why we are moving away from the LuCE acronym and using Lung Cancer Europe in full, every time.

What’s changed?

The change is simple.

We are no longer using LuCE as our shortcut name or as part of our logo.

Our logo now leads with the full name Lung Cancer Europe.

This makes the organisation easier to recognise, easier to understand and easier to find.

What’s stayed the same?

This is not a new organisation and it is not a full rebrand.

The blue is the same.
The lung mark is the same.
The typography is from the same family, just a little stronger and tighter.
Our purpose is the same.

We are still the voice of Europeans impacted by or at risk of lung cancer.

What has changed is the way we present ourselves. Our identity now says more clearly who we are and who we are here for.

Why now?

Lung Cancer Europe has spent thirteen years building trust, relationships and evidence across Europe.

In that time, the organisation has changed. Our member network has grown. Our policy and advocacy work has grown. Our digital reach has grown. Our projects now sit across treatment access, mental health, biomarker testing, early diagnosis, lived experience, digital information and member support.

As that work has expanded, clarity has become more important.

LuCE made sense when the organisation was smaller and when most people already knew what it stood for. But an acronym can become a barrier. If you know it, you know it. If you do not, it gives you very little to work with.

Lung Cancer Europe says exactly what we are.

A single home from 1 July

The identity update goes live from 1 July 2026.

From that date, our website, social channels, team email signatures, reports, templates and key documents will start using the updated Lung Cancer Europe identity.

Our website has also been rebuilt and will continue to be updated over the coming months. It will be our single permanent home for news, resources, reports, projects and organisational updates.

New logo files and guidelines

Our updated logo files, brand guidelines and assets will now be available on our website.

These will include our logo files, guidance on how to use the Lung Cancer Europe identity, and materials to help our members, partners and supporters use the updated name and logo consistently.

How you can support the change

We would really appreciate the support of our member organisations, partners and supporters as we make this change.

From 1 July, please use Lung Cancer Europe in full and use the updated logo and assets wherever you refer to us. This includes websites, presentations, reports, event materials, newsletters and social media posts.

Small changes like this make a real difference. The more consistently we all use the same name and identity, the easier it is for people to recognise Lung Cancer Europe, understand our work and find us.

Looking ahead

This update is about clarity.

It keeps what people already recognise while removing something that was no longer helping us explain who we are.

Lung Cancer Europe is growing, and our identity needs to grow with us.

We are Lung Cancer Europe, in full, every time.

Previous
Previous

Access to Treatment Atlas: compare lung cancer treatment access across Europe

Next
Next

What the EU Critical Medicines Act means for lung cancer